chr10-88667352-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004190.4(LIPF):c.55G>T(p.Gly19Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,613,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004190.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIPF | NM_004190.4 | c.55G>T | p.Gly19Cys | missense_variant | 2/10 | ENST00000238983.9 | NP_004181.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPF | ENST00000238983.9 | c.55G>T | p.Gly19Cys | missense_variant | 2/10 | 1 | NM_004190.4 | ENSP00000238983 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251212Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135766
GnomAD4 exome AF: 0.000107 AC: 157AN: 1461216Hom.: 0 Cov.: 29 AF XY: 0.0000990 AC XY: 72AN XY: 726956
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 17, 2023 | The c.85G>T (p.G29C) alteration is located in exon 3 (coding exon 2) of the LIPF gene. This alteration results from a G to T substitution at nucleotide position 85, causing the glycine (G) at amino acid position 29 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at